Gossamer Bio Other Long Term Liabilities (Quarterly) Insights

Gossamer Bio, Inc. (GOSS)

0.4233 -1.71 (-80.13%) USD | NASDAQ | Feb 23, 16:00

0.383 -0.04 (-9.52%) After-Hours: 06:52

View Other Long Term Liabilities (Quarterly) for GOSS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Madrigal Pharmaceuticals, Inc.	--
XOMA Royalty Corp.	Upgrade
Rezolute, Inc.	--
Axsome Therapeutics, Inc.	Upgrade
Crinetics Pharmaceuticals, Inc.	Upgrade